CNBX Pharmaceuticals Inc.

CNBX Pharmaceuticals Inc.

Biotechnology • Healthcare • Bethesda, MD, United States • CNBX (PNK)

CNBX Pharmaceuticals Inc., a clinical-stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug candidates, including PLP-33 for the local treatment of lateral spreading, or sessile, colorectal polyps during colonoscopy, BRST-33 for the treatment of breast cancer, MLN-33 for the treatment of melanoma, and PRST-33 for the treatment of prostate cancer. In addition, it is developing RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland.

877 424 2429 #3 Bethesda Metro Center, Bethesda, MD 20814, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

CNBX stock CNBX Pharmaceuticals Inc. (PNK) $0.0006 08 Jan 2026: Earnings on Jan 12 could move value - Meyka
Meyka • Jan 8
Nine of the largest pharma companies ink deals with Trump to lower drug prices - CNBC
CNBC • Dec 19
Trump says pharma tariffs could eventually reach up to 250% - CNBC
CNBC • Aug 5
CNBX Stock - technical420.com
technical420.com • Mar 24
Pharma giants push for tariff clarity as ambiguity threatens EU-U.S. deal - CNBC
CNBC • Jul 29

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has CNBX Pharmaceuticals Inc. had layoffs?
No layoff events have been recorded for CNBX Pharmaceuticals Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does CNBX Pharmaceuticals Inc. have?
CNBX Pharmaceuticals Inc. has approximately 1 employees.
What industry is CNBX Pharmaceuticals Inc. in?
CNBX Pharmaceuticals Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is CNBX Pharmaceuticals Inc. a publicly traded company?
Yes, CNBX Pharmaceuticals Inc. is publicly traded under the ticker symbol CNBX on the PNK. The company has a market capitalization of approximately $0.00 billion.
Where is CNBX Pharmaceuticals Inc. headquartered?
CNBX Pharmaceuticals Inc. is headquartered in Bethesda, MD, United States at #3 Bethesda Metro Center, Bethesda, MD 20814, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.